{"id":1232,"date":"2018-05-29T19:52:07","date_gmt":"2018-05-29T19:52:07","guid":{"rendered":"http:\/\/cdafound.org\/?page_id=1232"},"modified":"2021-09-29T15:10:53","modified_gmt":"2021-09-29T15:10:53","slug":"gpro_faq","status":"publish","type":"page","link":"https:\/\/cdafound.org\/zh\/gpro_faq\/","title":{"rendered":"GPRO \u5e38\u89c1\u95ee\u9898\u89e3\u7b54"},"content":{"rendered":"<p><strong style=\"color: #993333;\">\u4ec0\u4e48\u662f\u5168\u7403\u91c7\u8d2d\u57fa\u91d1\uff1f<\/strong><br \/>\nGPRO \u662f\u4e00\u5bb6\u975e\u8425\u5229\u7ec4\u7ec7\uff0c\u5176\u4f7f\u547d\u662f\u5e2e\u52a9\u5404\u7ec4\u7ec7\uff08\u6c11\u95f4\u793e\u4f1a\u7ec4\u7ec7\u3001\u975e\u653f\u5e9c\u7ec4\u7ec7\u3001\u516c\u79c1\u536b\u751f\u7cfb\u7edf\u3001\u56fd\u5bb6\u653f\u5e9c\u7b49\uff09\u91c7\u8d2d\u4ef7\u683c\u5408\u7406\u7684\u809d\u708e\u836f\u7269\u548c\u8bca\u65ad\u8bd5\u5242\u3002GPRO \u662f\u75be\u75c5\u5206\u6790\u4e2d\u5fc3\u57fa\u91d1\u4f1a (CDAF) \u7684\u4e00\u9879\u91cd\u8981\u5021\u8bae\uff0c\u91cd\u70b9\u5173\u6ce8\u4e2d\u4f4e\u6536\u5165\u56fd\u5bb6\/\u5730\u533a\u3002GPRO \u6210\u7acb\u4e8e 2017 \u5e74\uff0c\u65e8\u5728\u4ee5\u9884\u5148\u534f\u5546\u7684\u6298\u6263\u4ef7\u6269\u5927\u4f18\u8d28\u4e59\u809d\u548c\u4e19\u809d\u8bca\u65ad\u68c0\u6d4b\u548c\u6cbb\u7597\u7684\u53ef\u53ca\u6027\u3002<\/p>\n<p><strong style=\"color: #993333;\">\u4e0e GPRO \u5408\u4f5c\u6709\u54ea\u4e9b\u597d\u5904\uff1f<\/strong><br \/>\n<em>\u6709\u7ade\u4e89\u529b\u7684\u4ef7\u683c<\/em>\uff1aGPRO \u901a\u8fc7\u96c6\u4e2d\u91c7\u8d2d\u673a\u5236\uff0c\u80fd\u591f\u6574\u5408\u5404\u6210\u5458\u673a\u6784\u7684\u8ba2\u5355\u3002\u66f4\u9ad8\u7684\u8ba2\u5355\u91cf\u4f7f GPRO \u80fd\u591f\u534f\u5546\u51fa\u6bd4\u5927\u591a\u6570\u673a\u6784\u5355\u72ec\u534f\u5546\u66f4\u4f4e\u7684\u836f\u54c1\u548c\u8bca\u65ad\u4ef7\u683c\u3002<\/p>\n<p><em>\u8d28\u91cf\u4fdd\u8bc1<\/em>\uff1a\u901a\u8fc7 GPRO \u63d0\u4f9b\u7684\u6240\u6709\u836f\u54c1\u5747\u5df2\u83b7\u5f97\u4ee5\u4e0b\u4eba\u5458\u4f7f\u7528\u6388\u6743\uff1a<\/p>\n<ul>\n<li>WHO \u9884\u8ba4\u8bc1\u6216 FDA \u4e34\u65f6\u6279\u51c6<\/li>\n<li>\u4e25\u683c\u76d1\u7ba1\u673a\u6784\uff08SRA\uff09<\/li>\n<li>\u5f53\u65e0\u6cd5\u83b7\u5f97\u8d44\u683c\u9884\u5ba1\u3001FDA \u4e34\u65f6\u6279\u51c6\u6216 SRA \u65f6\uff0c\u7531\u72ec\u7acb\u4e13\u5bb6\u5ba1\u67e5\u5c0f\u7ec4 (ERP) \u8fdb\u884c\u5ba1\u67e5<strong>\u00a0<\/strong><\/li>\n<\/ul>\n<p><strong style=\"color: #993333;\">GPRO \u63d0\u4f9b\u54ea\u4e9b\u4ea7\u54c1\uff1f<\/strong><br \/>\nGPRO \u63d0\u4f9b\u4ee5\u4e0b\u8d28\u91cf\u4fdd\u8bc1\u7684\u4ea7\u54c1\uff1a<\/p>\n<ul>\n<li><em>\u7b5b\u67e5<\/em>\uff1aCE \u8ba4\u8bc1\u7684 HBV \u548c HCV \u5feb\u901f\u8bca\u65ad\u68c0\u6d4b (RDT)<\/li>\n<li><em>\u8bca\u65ad<\/em>: Cepheid GeneXpert \u75c5\u6bd2\u8f7d\u91cf\u8bca\u65ad\u7cfb\u7edf (NAT)<\/li>\n<li><em>\u4e59\u809d\/\u4e19\u809d\u836f\u7269<\/em>\uff1a\u7d22\u975e\u5e03\u97e6\u3001\u8fbe\u62c9\u4ed6\u97e6\u3001\u66ff\u8bfa\u798f\u97e6\u3001\u6069\u66ff\u5361\u97e6<\/li>\n<\/ul>\n<p>GPRO \u53ea\u4e0e\u62e5\u6709\u7ecf\u8425\u81ea\u7531\u7684\u5236\u9020\u5546\u5408\u4f5c\u2014\u2014\u8981\u4e48\u62e5\u6709<br \/>\n\u53d1\u8d77\u516c\u53f8\u6216\u62e5\u6709\u836f\u54c1\u4e13\u5229\u6c60\u8bb8\u53ef\u7684\u516c\u53f8\u3002<\/p>\n<p><strong style=\"color: #993333;\">GPRO \u6536\u53d6\u7684\u52a0\u4ef7\u662f\u591a\u5c11\uff1f<\/strong><br \/>\n\u4ea7\u54c1\u7684\u6700\u7ec8\u6210\u672c\u5c06\u662f\u4ee5\u4e0b\u6210\u672c\u7684\u603b\u548c\uff1a<\/p>\n<ul>\n<li>\u4ea7\u54c1\u4ef7\u683c\uff08\u836f\u54c1\u548c\/\u6216\u8bca\u65ad\u4ea7\u54c1\uff09\u2014\u2014\u4e0e\u5236\u9020\u5546\u9884\u5148\u534f\u5546<\/li>\n<li>\u8fd0\u8d39+\u4fdd\u9669\u8d39\u2014\u2014\u4e0e\u5236\u9020\u5546\u9884\u5148\u534f\u5546<\/li>\n<li>\u8fdb\u53e3\u7a0e\u2014\u2014\u4e0e\u56fd\u5bb6\/\u5730\u533a\u9884\u5148\u534f\u5546<\/li>\n<li>\u4ea7\u54c1\u4ef7\u683c\u4e0a\u6da8 5%\uff08\u4e0d\u542b\u8fd0\u8d39\u3001\u4fdd\u9669\u8d39\u548c\u8fdb\u53e3\u7a0e\uff09<\/li>\n<\/ul>\n<p><strong style=\"color: #993333;\">\u7ec4\u7ec7\u5982\u4f55\u4e0e GPRO \u5408\u4f5c\uff1f<\/strong><\/p>\n<p><a href=\"http:\/\/cdafound.org\/zh\/gpro_process\/\">\u4e0e GPRO \u5408\u4f5c<\/a><\/p>\n<p><strong style=\"color: #993333;\">\u6211\u7684\u56fd\u5bb6\/\u5730\u533a\u6709\u54ea\u4e9b\u4ea7\u54c1\uff1f<\/strong><\/p>\n<p><iframe loading=\"lazy\" src=\"http:\/\/cdafound.org\/polaris_view\/wp_gpro_access.htm\" width=\"850px\" height=\"500px\" frameborder=\"0\"><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\"><\/span><\/iframe><\/p>\n<p><iframe loading=\"lazy\" src=\"http:\/\/cdafound.org\/polaris_view\/wp_gpro_access2.htm\" width=\"850px\" height=\"500px\" frameborder=\"0\"><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\"><\/span><\/iframe><\/p>","protected":false},"excerpt":{"rendered":"<p>WHAT IS THE GLOBAL PROCUREMENT FUND? GPRO is a non-profit organization whose mission is to help organizations (CSOs, NGOs, public &amp; private health systems, national governments, etc.) procure affordable hepatitis medicines and diagnostics.\u00a0 GPRO is a major initiative of the Center for Disease Analysis Foundation (CDAF) and focuses on low and middle-income countries\/territories. GPRO was [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[],"class_list":["post-1232","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/pages\/1232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/comments?post=1232"}],"version-history":[{"count":48,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/pages\/1232\/revisions"}],"predecessor-version":[{"id":4713,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/pages\/1232\/revisions\/4713"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/media?parent=1232"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/subtheme?post=1232"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}